DIAアカウントをお持ちの場合、サインインしてください。

サインイン

ユーザーIDをお忘れですか? or パスワードをお忘れですか?

Hulic Conference

2018年8月23日 (木) 午前 9:30 - 2018年8月24日 (金) 午後 5:00

Hulic Asakusabashi Building, 1-22-16 Asakusa, Taito-ku, Tokyo, 111-0053 Japan

5th DIA European Medicines Regulations Training Course

This course will give you an overview of the European regulatory system to provide you with the tools you need to develop a successful regulatory strategy.

概要

Click Here to View the Program

This course will give you an overview of the European regulatory system to provide you with the tools you need to develop a successful regulatory strategy. You will be given information about the different routes for obtaining a license for the European market, including centralized or decentralized procedures; mutual recognition procedures; national procedures; and the specific procedures for orphan drugs, pediatrics, advanced therapies, and combination products. The course will cover the different steps and time lines for each procedure, the clockstops, the compiling of questions, and other key topics.

You’ll also receive a brief introduction to the unique set up of the European regulatory environment, including the different responsibilities of the European Commission, the member states, the European Medicines Agency (EMA), the National Competent Authorities (NCAs), and the Heads of Medicines Agencies (HMA).

Please note: the language of this training course will be English only, but Japanese speaking will be welcomed during group discussions.

プログラム委員会

  • Masayoshi  Higuchi
    Masayoshi Higuchi Head of Quality & Regulatory Compliance Unit,
    Chugai Pharmaceutical Co., Ltd., Japan
  • Akiko  Ikeda, RPh
    Akiko Ikeda, RPh Associate Director, Regulatory Development Dept.
    Janssen Pharmaceutical K.K., Japan
  • Yumi  Inukai
    Yumi Inukai New Drug Regulatory Affairs Dept.
    Daiichi Sankyo Co., Ltd., Japan
  • Miyuki  Kaneko
    Miyuki Kaneko Japan Regulatory Portfolio Lead, Regulatory Affairs
    Pfizer R&D Japan G.K., Japan
  • Yomei  Matsuoka, MSc, RPh
    Yomei Matsuoka, MSc, RPh Vice President, Pharmacoepidemiology and PMS Department
    Daiichi Sankyo Co., Ltd., Japan
  • Miwa  Tamada
    Miwa Tamada Manager, New Drug RA Department, Regulatory Affairs
    GlaxoSmithKline K.K., Japan

Digital Learning Catalog

DIA Learning: eLearning Soultions
Download

最新情報や機会を逃さないで

DIAのメールを購読すれば、常に最新の業界情報やイベント情報を得ることができます。